Bioqual Statistics
Total Valuation
Bioqual has a market cap or net worth of 27.40 million. The enterprise value is 44.10 million.
| Market Cap | 27.40M |
| Enterprise Value | 44.10M |
Important Dates
The next estimated earnings date is Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioqual has 894,416 shares outstanding.
| Current Share Class | 894,416 |
| Shares Outstanding | 894,416 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | n/a |
| Float | 205,671 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 77.98 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.10 |
| EV / EBITDA | 16.54 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 1.01.
| Current Ratio | 4.22 |
| Quick Ratio | 4.16 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 12.27 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.16% and return on invested capital (ROIC) is -8.57%.
| Return on Equity (ROE) | -12.16% |
| Return on Assets (ROA) | -4.45% |
| Return on Invested Capital (ROIC) | -8.57% |
| Return on Capital Employed (ROCE) | -7.20% |
| Weighted Average Cost of Capital (WACC) | 1.92% |
| Revenue Per Employee | 353,517 |
| Profits Per Employee | -36,890 |
| Employee Count | 113 |
| Asset Turnover | 0.64 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bioqual has paid 452,495 in taxes.
| Income Tax | 452,495 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.75% in the last 52 weeks. The beta is -0.01, so Bioqual's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -18.75% |
| 50-Day Moving Average | 52.12 |
| 200-Day Moving Average | 72.84 |
| Relative Strength Index (RSI) | 16.09 |
| Average Volume (20 Days) | 694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, Bioqual had revenue of 39.95 million and -4.17 million in losses. Loss per share was -4.66.
| Revenue | 39.95M |
| Gross Profit | 6.35M |
| Operating Income | -4.47M |
| Pretax Income | -3.72M |
| Net Income | -4.17M |
| EBITDA | -2.25M |
| EBIT | -4.47M |
| Loss Per Share | -4.66 |
Balance Sheet
The company has 16.01 million in cash and 32.71 million in debt, with a net cash position of -16.69 million or -18.66 per share.
| Cash & Cash Equivalents | 16.01M |
| Total Debt | 32.71M |
| Net Cash | -16.69M |
| Net Cash Per Share | -18.66 |
| Equity (Book Value) | 32.41M |
| Book Value Per Share | 36.23 |
| Working Capital | 20.48M |
Cash Flow
In the last 12 months, operating cash flow was 351,444 and capital expenditures -418,220, giving a free cash flow of -66,776.
| Operating Cash Flow | 351,444 |
| Capital Expenditures | -418,220 |
| Depreciation & Amortization | 2.22M |
| Net Borrowing | n/a |
| Free Cash Flow | -66,776 |
| FCF Per Share | -0.07 |
Margins
Gross margin is 15.90%, with operating and profit margins of -11.19% and -10.44%.
| Gross Margin | 15.90% |
| Operating Margin | -11.19% |
| Pretax Margin | -9.30% |
| Profit Margin | -10.44% |
| EBITDA Margin | -5.64% |
| EBIT Margin | -11.19% |
| FCF Margin | n/a |
Dividends & Yields
Bioqual does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.21% |
| FCF Yield | -0.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Oct 28, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
Bioqual has an Altman Z-Score of 1.82 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.82 |
| Piotroski F-Score | 3 |